Outlook Therapeutics Announces Reverse Stock Split Nasdaq
CRANBURY, N.J., March 15, 2019– Outlook Therapeutics, Inc. announced today that its Board of Directors has approved a 1- for-8 reverse stock split.
Outlook Therapeutics Announces Reverse Stock Split Nasdaq
CRANBURY, N.J., March 15, 2019– Outlook Therapeutics, Inc. announced today that its Board of Directors has approved a 1- for-8 reverse stock split.